CN103645322A - 一种链霉素的化学发光酶联免疫检测试剂盒 - Google Patents
一种链霉素的化学发光酶联免疫检测试剂盒 Download PDFInfo
- Publication number
- CN103645322A CN103645322A CN201310673607.1A CN201310673607A CN103645322A CN 103645322 A CN103645322 A CN 103645322A CN 201310673607 A CN201310673607 A CN 201310673607A CN 103645322 A CN103645322 A CN 103645322A
- Authority
- CN
- China
- Prior art keywords
- streptomysin
- solution
- elisa
- kit
- streptomycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002965 ELISA Methods 0.000 title claims abstract description 52
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 title claims abstract description 44
- 229960005322 streptomycin Drugs 0.000 title claims abstract description 23
- 239000000243 solution Substances 0.000 claims abstract description 49
- 239000000427 antigen Substances 0.000 claims abstract description 17
- 102000036639 antigens Human genes 0.000 claims abstract description 17
- 108091007433 antigens Proteins 0.000 claims abstract description 17
- 241001465754 Metazoa Species 0.000 claims abstract description 15
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 10
- 230000008878 coupling Effects 0.000 claims abstract description 10
- 238000010168 coupling process Methods 0.000 claims abstract description 10
- 238000005859 coupling reaction Methods 0.000 claims abstract description 10
- 108010058846 Ovalbumin Proteins 0.000 claims abstract description 7
- 229940092253 ovalbumin Drugs 0.000 claims abstract description 7
- 239000012086 standard solution Substances 0.000 claims abstract description 7
- 239000004793 Polystyrene Substances 0.000 claims abstract description 5
- 229920002223 polystyrene Polymers 0.000 claims abstract description 5
- 238000001514 detection method Methods 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 19
- 238000004020 luminiscence type Methods 0.000 claims description 18
- 239000000872 buffer Substances 0.000 claims description 14
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- 241001494479 Pecora Species 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 6
- 150000003016 phosphoric acids Chemical class 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 230000002163 immunogen Effects 0.000 claims description 4
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 229940078916 carbamide peroxide Drugs 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 13
- 230000035945 sensitivity Effects 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 7
- 238000003556 assay Methods 0.000 abstract description 3
- 238000008157 ELISA kit Methods 0.000 abstract 2
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 abstract 1
- 238000003149 assay kit Methods 0.000 abstract 1
- 239000003640 drug residue Substances 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
- 238000005201 scrubbing Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000012530 fluid Substances 0.000 description 4
- 210000004408 hybridoma Anatomy 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 231100000703 Maximum Residue Limit Toxicity 0.000 description 3
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000003547 immunosorbent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000013048 microbiological method Methods 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000204022 Mycoplasma gallisepticum Species 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241000594182 Sarcophaga sigma Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310673607.1A CN103645322B (zh) | 2013-12-12 | 2013-12-12 | 一种链霉素的化学发光酶联免疫检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310673607.1A CN103645322B (zh) | 2013-12-12 | 2013-12-12 | 一种链霉素的化学发光酶联免疫检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103645322A true CN103645322A (zh) | 2014-03-19 |
CN103645322B CN103645322B (zh) | 2015-12-30 |
Family
ID=50250573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310673607.1A Active CN103645322B (zh) | 2013-12-12 | 2013-12-12 | 一种链霉素的化学发光酶联免疫检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103645322B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104897650A (zh) * | 2014-12-25 | 2015-09-09 | 北京勤邦生物技术有限公司 | 一种卡那霉素的化学发光试剂盒及其应用 |
CN106771210A (zh) * | 2016-11-23 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中呕吐毒素的检测试剂盒 |
CN106771140A (zh) * | 2016-11-22 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中链霉素的检测试剂盒 |
CN107677660A (zh) * | 2016-09-30 | 2018-02-09 | 青岛大学 | 一种吉他霉素化学发光酶联免疫检测试剂盒 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010240A2 (en) * | 2005-07-18 | 2007-01-25 | European Cardiovascular Genetics Foundation | Method for high-throughput screening |
CN101201354A (zh) * | 2006-12-14 | 2008-06-18 | 北京科美东雅生物技术有限公司 | 甲状腺素化学发光免疫分析定量测定试剂盒及制备方法 |
CN101936986A (zh) * | 2010-08-03 | 2011-01-05 | 中国农业大学 | 一种检测地西泮的方法及其专用化学发光免疫试剂盒 |
CN102928411A (zh) * | 2011-08-09 | 2013-02-13 | 北京勤邦生物技术有限公司 | 检测链霉素的磁颗粒化学发光试剂盒及其应用 |
CN103018450A (zh) * | 2011-09-20 | 2013-04-03 | 北京勤邦生物技术有限公司 | 一种氯霉素的化学发光酶联免疫检测试剂盒 |
-
2013
- 2013-12-12 CN CN201310673607.1A patent/CN103645322B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010240A2 (en) * | 2005-07-18 | 2007-01-25 | European Cardiovascular Genetics Foundation | Method for high-throughput screening |
CN101201354A (zh) * | 2006-12-14 | 2008-06-18 | 北京科美东雅生物技术有限公司 | 甲状腺素化学发光免疫分析定量测定试剂盒及制备方法 |
CN101936986A (zh) * | 2010-08-03 | 2011-01-05 | 中国农业大学 | 一种检测地西泮的方法及其专用化学发光免疫试剂盒 |
CN102928411A (zh) * | 2011-08-09 | 2013-02-13 | 北京勤邦生物技术有限公司 | 检测链霉素的磁颗粒化学发光试剂盒及其应用 |
CN103018450A (zh) * | 2011-09-20 | 2013-04-03 | 北京勤邦生物技术有限公司 | 一种氯霉素的化学发光酶联免疫检测试剂盒 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104897650A (zh) * | 2014-12-25 | 2015-09-09 | 北京勤邦生物技术有限公司 | 一种卡那霉素的化学发光试剂盒及其应用 |
CN107677660A (zh) * | 2016-09-30 | 2018-02-09 | 青岛大学 | 一种吉他霉素化学发光酶联免疫检测试剂盒 |
CN107677660B (zh) * | 2016-09-30 | 2020-11-24 | 厦门中集信检测技术有限公司 | 一种吉他霉素化学发光酶联免疫检测试剂盒 |
CN106771140A (zh) * | 2016-11-22 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中链霉素的检测试剂盒 |
CN106771210A (zh) * | 2016-11-23 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中呕吐毒素的检测试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN103645322B (zh) | 2015-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103018454B (zh) | 一种磺胺类药物的化学发光酶联免疫检测试剂盒 | |
CN101413943B (zh) | 一种检测三聚氰胺的方法及其专用酶联免疫试剂盒 | |
CN101571539B (zh) | 检测头孢类药物的酶联免疫试剂盒及其应用 | |
CN103575890A (zh) | 一种莱克多巴胺的化学发光试剂盒及其应用 | |
CN102967709B (zh) | 检测玉米赤霉烯酮药物的酶联免疫试剂盒及其应用 | |
CN101776685B (zh) | 检测三甲氧苄胺嘧啶药物的酶联免疫试剂盒及其应用 | |
CN103645322B (zh) | 一种链霉素的化学发光酶联免疫检测试剂盒 | |
CN101839918B (zh) | 一种检测螺旋霉素的方法及其专用酶联免疫试剂盒 | |
CN1811436B (zh) | 一种检测恩诺沙星的方法及其专用酶联免疫试剂盒 | |
CN104897896A (zh) | 一种林可霉素的磁免疫化学发光检测试剂盒及其应用 | |
CN103018453B (zh) | 一种喹诺酮类药物的化学发光酶联免疫检测试剂盒 | |
CN102079789A (zh) | 一种检测马杜霉素的方法及其专用酶联免疫试剂盒 | |
CN101358967B (zh) | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 | |
CN107677807A (zh) | 一种吉他霉素磁免疫化学发光检测试剂盒 | |
CN101368953A (zh) | 一种环丙沙星的化学发光酶联免疫检测试剂盒 | |
CN109180519B (zh) | 一种喹乙醇代谢物抗原、抗体及酶联免疫检测试剂盒与检测方法 | |
CN101299046A (zh) | 一种检测红霉素类化合物的方法及其专用酶联免疫试剂盒 | |
CN103323594B (zh) | 一种检测水产品中喹诺酮类药物的酶联免疫试剂盒及其应用 | |
CN103698519B (zh) | 一种呋喃它酮代谢物的化学发光检测试剂盒及其应用 | |
CN104897651A (zh) | 一种黄曲霉毒素m1的化学发光试剂盒及其应用 | |
CN101315377A (zh) | 一种检测莫能菌素的方法及其专用酶联免疫试剂盒 | |
CN111377888B (zh) | 一种闹羊花毒素iii半抗原及其制备方法与应用 | |
CN109734675B (zh) | 一种适用于检测兽药制剂中喹乙醇含量的方法及产品 | |
CN103420879B (zh) | 氨苯砜半抗原及其制备方法和应用 | |
CN101349694A (zh) | 一种链霉素药物快速检测试剂盒及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20160822 Granted publication date: 20151230 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170116 Granted publication date: 20151230 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xiumei Inventor after: Xiang Chaorong Inventor after: Zhong Weiping Inventor after: Wang Junxia Inventor after: Wang Yanfeng Inventor after: Pan Yanyan Inventor after: Yang Liangzhen Inventor after: Zhang Chunyan Inventor after: Wu Weijie Inventor after: Zhang Baogui Inventor after: Wang Damin Inventor after: Liu He Inventor after: Li Zejun Inventor after: Jiang Changcheng Inventor before: Wang Shanpu Inventor before: Liu Panpan Inventor before: Zheng Ming Inventor before: Wang Yudong Inventor before: Zhi Xueling |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170316 Address after: 471000 Luoyang, Luolong, science and Technology Park, west of Peony Road, No. N3, No. Patentee after: LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD. Patentee after: Luoyang Modern Biotechnology Research Institute Co., Ltd. Address before: 471000 Luoyang, Luolong, science and Technology Park, west of Peony Road, No. N3, No. Patentee before: LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right |